Correlation Between Bluejay Diagnostics and Rapid Therapeutic

Can any of the company-specific risk be diversified away by investing in both Bluejay Diagnostics and Rapid Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluejay Diagnostics and Rapid Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bluejay Diagnostics and Rapid Therapeutic Science, you can compare the effects of market volatilities on Bluejay Diagnostics and Rapid Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluejay Diagnostics with a short position of Rapid Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluejay Diagnostics and Rapid Therapeutic.

Diversification Opportunities for Bluejay Diagnostics and Rapid Therapeutic

-0.33

Correlation Coefficient

Bluejay Diagnostics  Rapid Therapeutic

Very good diversification

The 3 months correlation between Bluejay and Rapid is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and Rapid Therapeutic Science in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapid Therapeutic Science and Bluejay Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluejay Diagnostics are associated (or correlated) with Rapid Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapid Therapeutic Science has no effect on the direction of Bluejay Diagnostics i.e., Bluejay Diagnostics and Rapid Therapeutic go up and down completely randomly.

Pair Corralation between Bluejay Diagnostics and Rapid Therapeutic

Given the investment horizon of 90 days Bluejay Diagnostics is expected to generate 4.3 times less return on investment than Rapid Therapeutic. But when comparing it to its historical volatility, Bluejay Diagnostics is 1.62 times less risky than Rapid Therapeutic. It trades about 0.09 of its potential returns per unit of risk. Rapid Therapeutic Science is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  0.10  in Rapid Therapeutic Science on October 26, 2024 and sell it today you would earn a total of  0.30  from holding Rapid Therapeutic Science or generate 300.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	97.5%
Values	Daily Returns

Bluejay Diagnostics  vs.  Rapid Therapeutic Science

Bluejay Diagnostics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bluejay Diagnostics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile fundamental indicators, Bluejay Diagnostics showed solid returns over the last few months and may actually be approaching a breakup point.

Rapid Therapeutic Science

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Rapid Therapeutic Science are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Rapid Therapeutic disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bluejay Diagnostics and Rapid Therapeutic

The main advantage of trading using opposite Bluejay Diagnostics and Rapid Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluejay Diagnostics position performs unexpectedly, Rapid Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapid Therapeutic will offset losses from the drop in Rapid Therapeutic's long position.

The idea behind Bluejay Diagnostics and Rapid Therapeutic Science pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.